No Data
VolitionRx Converts Debt to Equity Through Share Issuances
Maxim Group Initiates VolitionRX(VNRX.US) With Buy Rating, Announces Target Price $4
VolitionRx Resumed With a Buy at Maxim
VolitionRx Partners With Sysmex To Streamline Volition's Nu.Q NETs H3.1 Assay
VolitionRx Announces Collaboration With Sysmex
12 Health Care Stocks Moving In Thursday's After-Market Session
loading...